Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design

Journal of Advanced Pharmaceutical Technology and Research

Volumn 3, Issue 1, 2012, Pages 30-40

  Singh, Gurinder ^a   Pai, Roopa S ^a   Kusum Devi, V ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Central composite design; extrusion spheronization; furosemide; statistical analysis; Taguchi orthogonal array design

Indexed keywords

FUROSEMIDE; MICROCRYSTALLINE CELLULOSE; POLYMER;

ARTICLE; COMPOSITE MATERIAL; CONTROLLED STUDY; DRUG COATING; DRUG DESIGN; DRUG PELLET; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; ENCAPSULATION; PARTICLE SIZE; PELLET EXTRUSION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SPHERONIZATION; STOMACH PH; SURFACE PROPERTY; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; VALIDATION PROCESS;

EID: 84858838616     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/2231-4040.93565     Document Type: Article

References (17)

1. Gandhi R, Kaul CL, Panchagnula R. Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharm Sci Technolo Today 1999;2:160-70.
2. Remington. The science and practice of pharmacy. New Delhi: Wolters Kluwer; 2005.
3. Erkoboni DF. Extrusion/spheronization in: Pharmaceutical Extrusion Technology. New York: Marcel Dekker; 2003.
4. Harris MR, Ghebre-Sellasie I. Formulation variables in: Pharmaceutical Pelletization Technology. New York: Marcel Dekker; 1989.
5. Ott AD, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose. Eur J Pharm Biopharm 2009;71:38-46.
6. Schilling SU, Shah NH, Malick AW, McGinity JW. Properties of melt extruded enteric matrix pellets. Eur J Pharm Biopharm 2010;74;352-61.
7. Dayal P, Pillay V, Babu RJ, Singh M. Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: Characterization of viscosity, in vitro drug release, droplet size and dynamic surface tension. AAPS Pharm Sci Tech 2005;6: E573-85.
8. Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm Sci Tech 2006;7: E1-9.
9. Singh SK, Reddy IK, Khan MA. Optimization and characterization of controlled release pellets coated with experimental latex: II. Cationic drug. Int J Pharm 1996;141:179-95.
10. Gotti R, Furlanetto S, Andrisano V, Cavrini V, Pinzauti S. Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulphate. J Chromatogr 2000;875:411-22.
11. Lafuente CS, Furlanetto S, Arevalo MF, Fuentes JA, Rabasco AM, Faucci MT, et al. Didanosine extended-release matrix tablets: Optimization of formulation variables using statistical experimental design. Int J Pharm 2002;237:107-18.
12. Krogars K, Heinamaki J, Vesalahti J, Marvola M, Antikainen O, Yliruusi J. Extusion-spheronization of pH-sensitive polymeric matrix pellets for possible drug delivery. Int J Pharm 2000;199:187-94.
13. Klausner EA, Lavy E, Stepensky D, Cserepes E, Barta M, Friedman M, et al. Furosemide pharmacokinetics and pharmacodynamics following gastro retentive dosage form administration to healthy volunteers. J Clin Pharmacol 2003;43:711-20.
14. Exner HE, Link E. Image analysis for characterization of size and shape distribution of lead powders. Powder Metall Int 1977;9:131-3.
15. Singh R, Poddar SS, Chivate A. Sintering of wax for controlling release from pellets. AAPS Pharm Sci Tech 2007;8: E175-83.
16. Clarke GM, Newton JM, Short MB. Comparative gastrointestinal transit of pellet systems of varying density. Int J Pharm 1995;114:1-11.
17. Souto C, Rodriguez A, Parajes S, Pacheco RM. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm 2005;61:94-9.